ObsEva SA OBSEF
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- — / —
- Shares Outstanding
- 117.18M
- Market Cap
- $11,717.73
- Volume/Avg
- 115 / 7,411
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 6
- Website
- https://www.obseva.com
Valuation
|
Metric
|
OBSEF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
OBSEF
|
|---|---|
Quick Ratio | 1.21 |
Current Ratio | 2.23 |
Interest Coverage | −2.24 |
Quick Ratio
OBSEF
Profitability
|
Metric
|
OBSEF
|
|---|---|
Return on Assets (Normalized) | −41.53% |
Return on Equity (Normalized) | −227.14% |
Return on Invested Capital (Normalized) | −41.89% |
Return on Assets
OBSEF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|?XQC$l | LOCK|sjjh? | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|w@D<Y# | LOCK|@j&Vt | $83B | |||
| Moderna Inc
MRNA
| LOCK|wT?l%BD | LOCK|%x | $80B | |||
| argenx SE ADR
ARGX
| LOCK|l^$GFDB | LOCK|!cM | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|G?>Y<# | LOCK|pb | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|S>?!Wk | LOCK|&rv> | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|W>vP&Hm@ | LOCK|rw$S$ | $28B | |||
| Incyte Corp
INCY
| LOCK|WMg@yW% | LOCK|<@ | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|&?cDF?g | LOCK|WZ | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|zQGqr? | LOCK|PY | $14B |
United States